Details for Patent: 4,158,055
✉ Email this page to a colleague
Summary for Patent: 4,158,055
Title: | Administration of 16.alpha.,17.alpha.-cyclopentylidenedioxy-9.alpha.-fluor O-11.beta.,21-dihydroxy-1,4-pregnadiene-3,20-dione 21-acetate |
Abstract: | A method of treating topical inflammation in mammals by the administration of 16.alpha.,17.alpha.-cyclopentylidenedioxy-9.alpha.-fluoro-11.beta.,21-dihy droxy-1,4-pregnadiene-3,20-dione 21-acetate in a pharmaceutically acceptable carrier. |
Inventor(s): | Shultz; Walter (Spring Valley, NY), Sieger; George M. (Montvale, NJ), Krieger; Charles (Clifton, NJ) |
Assignee: | American Cyanamid Company (Stamford, CT) |
Application Number: | 05/754,917 |
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 4,158,055
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 4,158,055
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 7073674 | ⤷ Sign Up | |||
Belgium | 818929 | ⤷ Sign Up | |||
Switzerland | 601353 | ⤷ Sign Up | |||
Cyprus | 946 | ⤷ Sign Up | |||
Germany | 2437847 | ⤷ Sign Up | |||
France | 2240738 | ⤷ Sign Up | |||
United Kingdom | 1442925 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |